Monothematic on Cystic Fibrosis and Hepato-bilio-pancreatic Diseases in Children

General Information

Cystic Fibrosis is a multivisceral disease, that involves lung, gut, and liver, as well as other systems. Since 2012, several CFTR-modulating therapies have been developed targeting the underlying molecular defect. The real-life impact of these drugs is becoming CF into a chronic disease, and its impact on different organs is until now, unknown.

These therapies are transforming CF into a chronic condition; however, their long-term impact on extrapulmonary organs remains incompletely understood.

Cystic fibrosis–related liver disease (CFLD) must be carefully distinguished from other hepatic manifestations that may lack clinical significance. Both the clinical presentation and histological severity of CFLD are highly variable among patients.

This conference provides an opportunity to deepen our understanding of CFLD pathogenesis, current diagnostic and management strategies, and to evaluate the emerging evidence on how CFTR modulators may influence hepatobiliary outcomes in CF.

The course language is English.

Registration & Fees

Registration Deadline: February 15, 2027
Registration Fees:
ESPGHAN Member Regular: EUR 250.00
ESPGHAN Trainee Member (YE): EUR 150.00
Non-Member General: EUR 300.00
Non-Member Trainee: EUR 250.00
 

Kindly use the online application form on this page. Applications submitted by email cannot be accepted. If you experience any issues with the tool, please contact us at office@espghan. Candidates will be selected based on an abstract that may be selected for presentation during the course. Abstracts may have been submitted to other public meetings previously. If you do not have a suitable abstract a motivation letter is required instead.

Please do not make travel arrangements before receipt of a formal confirmation of acceptance from the ESPGHAN Office. The number of participants is limited and a selection will be made by ESPGHAN after the deadline. Priority will be given to ESPGHAN Members.
ESPGHAN Members may attend two courses per year while non-members may attend one course before becoming members of the society. 

Delegates are expected to attend the full course and arrange their travel according to the course schedule. 

Abstract Submission Guidelines:
Language : English
Abstract word count : maximum 400
Title length: inclusive in total word count
Tables : maximum 2
Figure maximum 1
Details of authors: presenters name to be included and underlined
Number of coauthors : no restriction
Who can present : no restriction; any of the co-authors can present but should be registered for the school and have paid the registration fee. Presenters should have a medical / allied health professional background.
What can be submitted: preferrably complex / unresolved case reports or original work
Trial design abstract may be considered at the discretion of the abstract selection committee
Presentation: oral; Authors will be notified about selection.

PRELIMINARY PROGRAMME

Cost Coverage

ESPGHAN will cover the following for onsite delegates

• Accommodation on April 15 (arranged by ESPGHAN)
• Dinner on April 15
• Course catering 
• Course Material if applicable

CONTACT

If you have any questions, please contact the ESPGHAN Office for details.
Phone: +41 (0)22 9000 401
Email: office@espghan.org